[go: up one dir, main page]

AU5784799A - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them

Info

Publication number
AU5784799A
AU5784799A AU57847/99A AU5784799A AU5784799A AU 5784799 A AU5784799 A AU 5784799A AU 57847/99 A AU57847/99 A AU 57847/99A AU 5784799 A AU5784799 A AU 5784799A AU 5784799 A AU5784799 A AU 5784799A
Authority
AU
Australia
Prior art keywords
polynucleotides encoding
secreted proteins
secreted
proteins
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57847/99A
Inventor
Jeff Hall
Heidi Hoffman
Peter Rapiejko
Dario Valenzuela
Olive Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alphagene Inc
Original Assignee
Alphagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alphagene Inc filed Critical Alphagene Inc
Publication of AU5784799A publication Critical patent/AU5784799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
AU57847/99A 1998-08-24 1999-08-24 Secreted proteins and polynucleotides encoding them Abandoned AU5784799A (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US9765998P 1998-08-24 1998-08-24
US9763898P 1998-08-24 1998-08-24
US60097638 1998-08-24
US60097659 1998-08-24
US9961898P 1998-09-09 1998-09-09
US60099618 1998-09-09
US10209298P 1998-09-28 1998-09-28
US60102092 1998-09-28
US10997898P 1998-11-25 1998-11-25
US60109978 1998-11-25
US11364598P 1998-12-23 1998-12-23
US11364698P 1998-12-23 1998-12-23
US60113645 1998-12-23
US60113646 1998-12-23
US37924699A 1999-08-23 1999-08-23
US09379246 1999-08-23
PCT/US1999/019351 WO2000011015A1 (en) 1998-08-24 1999-08-24 Secreted proteins and polynucleotides encoding them

Publications (1)

Publication Number Publication Date
AU5784799A true AU5784799A (en) 2000-03-14

Family

ID=27574713

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57847/99A Abandoned AU5784799A (en) 1998-08-24 1999-08-24 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP1107978A1 (en)
JP (1) JP2002537757A (en)
AU (1) AU5784799A (en)
CA (1) CA2340616A1 (en)
WO (1) WO2000011015A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030044839A1 (en) * 1997-09-17 2003-03-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7417126B2 (en) 1997-10-17 2008-08-26 Genentech, Inc. PRO246 antibodies
BR9915137A (en) * 1998-11-06 2004-06-08 Martin E Schwab Protein, purified protein fragment, purified molecule, nucleic acid, vector, recombinant cell, methods of producing a recombinant protein, treatment of an individual with a central nervous system neoplastic disease and damage to the central nervous system, inducing regeneration or sprouting of neurons in an individual, promoting structural plasticity of an individual's central nervous system, and recombinant non-human animal, method of obtaining polyclonal antibodies to a protein, isolated antiserum sample, and method of immunization of a non-human animal
EP2295573A1 (en) * 1998-11-20 2011-03-16 Arena Pharmaceuticals, Inc. Human orphan G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
AU3706600A (en) * 1999-02-26 2000-09-14 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
ATE363489T1 (en) * 1999-03-08 2007-06-15 Genentech Inc GENE SEQUENCES REPLICATED IN TUMORS AND THEIR DIAGNOSTIC USES
EP1189944A4 (en) * 1999-06-21 2002-09-11 Smithkline Beecham Corp G-PROTEIN COUPLED RECEPTOR AXOR16
AU6727900A (en) * 1999-08-27 2001-03-26 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
EP1225224A4 (en) * 1999-10-01 2004-03-24 Kyowa Hakko Kogyo Kk DNA REACTING TO SHEAR STRESS
WO2001025444A2 (en) * 1999-10-07 2001-04-12 Zymogenetics, Inc. Novel human phosphodiesterase zcytor13
EP1690872A3 (en) * 1999-12-01 2006-08-23 Genentech, Inc. Composition and methods for the diagnosis of tumours
AU2001263105A1 (en) 2000-05-18 2001-11-26 Lexicon Genetics Incorporated Human semaphorin homologs and polynucleotides encoding the same
AU2001269013A1 (en) * 2000-05-18 2001-11-26 Bayer Aktiengesellschaft Human galanin receptor-like g protein coupled receptor
WO2002004518A2 (en) * 2000-07-06 2002-01-17 Bayer Corporation Human neuropeptide y-like g protein-coupled receptor
WO2002074237A2 (en) * 2001-03-19 2002-09-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of kidney cancer
EP1293569A3 (en) * 2001-09-14 2004-03-31 Research Association for Biotechnology Full-length cDNAs
JP2003088388A (en) 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk NEW FULL-LENGTH cDNA
EP1440089A2 (en) * 2001-11-01 2004-07-28 Amersham plc Human angiomotin-like protein 1
AU2003221878A1 (en) 2002-04-12 2003-10-27 Schering Corporation G-protein coupled receptor ligands and methods
WO2004022086A1 (en) * 2002-09-02 2004-03-18 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
FR2848569A1 (en) * 2002-12-17 2004-06-18 Exonhit Therapeutics Sa New nucleic acid encoding variants of human kallikrein-3, useful for diagnosis of prostatic cancer and in screening for therapeutic agents, also related polypeptides and antibodies
WO2004106935A2 (en) * 2003-05-27 2004-12-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103)
EP2070546A1 (en) 2004-04-09 2009-06-17 Takeda Pharmaceutical Company Limited Preventives/remedies for cancer
JPWO2005100566A1 (en) 2004-04-14 2008-03-06 萬有製薬株式会社 Novel monkey GPR103, monkey QRFP, and method for evaluating compounds using GPR103
CN101772572A (en) * 2007-03-23 2010-07-07 新加坡科技研究局 Method of enhancing migration of neural precursor cells
EP3027656B1 (en) * 2013-07-30 2019-06-26 SBI Biotech Co., Ltd. Medicament comprising anti-phospholipase d4 antibody

Also Published As

Publication number Publication date
WO2000011015A1 (en) 2000-03-02
CA2340616A1 (en) 2000-03-02
JP2002537757A (en) 2002-11-12
EP1107978A1 (en) 2001-06-20

Similar Documents

Publication Publication Date Title
AU4081899A (en) Secreted proteins and polynucleotides encoding them
AU5784799A (en) Secreted proteins and polynucleotides encoding them
AU6050898A (en) Secreted proteins and polynucleotides encoding them
AU6777298A (en) Secreted proteins and polynucleotides encoding them
AU6578398A (en) Secreted proteins and polynucleotides encoding them
AU7159898A (en) Secreted proteins and polynucleotides encoding them
AU7807298A (en) Secreted proteins and polynucleotides encoding them
AU6702298A (en) Secreted proteins and polynucleotides encoding them
AU1101199A (en) Secreted proteins and polynucleotides encoding them
AU2685599A (en) Secreted proteins and polynucleotides encoding them
AU4189999A (en) Secreted proteins and polynucleotides encoding them
AU1417899A (en) Secreted proteins and polynucleotides encoding them
AU3965299A (en) Secreted proteins and polynucleotides encoding them
AU3457299A (en) Secreted proteins and polynucleotides encoding them
AU5828398A (en) Secreted proteins and polynucleotides encoding them
AU6337398A (en) Secreted proteins and polynucleotides encoding them
AU6590898A (en) Secreted proteins and polynucleotides encoding them
AU6546898A (en) Secreted proteins and polynucleotides encoding them
AU5801998A (en) Secreted proteins and polynucleotides encoding them
AU2997299A (en) Secreted proteins and polynucleotides encoding them
AU2669899A (en) Secreted proteins and polynucleotides encoding them
AU7826498A (en) Secreted proteins and polynucleotides encoding them
AU1536399A (en) Secreted proteins and polynucleotides encoding them
AU6765098A (en) Secreted proteins and polynucleotides encoding them
AU3489199A (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase